BORR vs NAT

BORR's Piotroski F-Score of 4/9 indicates borderline financial health, while the absence of an Altman Z-Score prevents a full distress risk assessment. The stock trades below its Graham Number of $5.01 at $4.47, suggesting modest undervaluation, though forward P/E of -47.51 signals expected earnings deterioration. Strong operating and gross margins contrast with high debt/equity of 1.80 and inconsistent earnings growth, particularly the recent Q/Q EPS decline of -35.7%. Technical trend is weak at 10/100, but dividend strength and insider sentiment are below average, contributing to a cautious outlook.

Despite a strong Piotroski F-Score of 8/9 indicating short-term operational health, NAT is fundamentally overvalued and financially unstable regarding its distributions. The current price of $5.53 trades at a massive premium to its Graham Number ($1.69) and Intrinsic Value ($1.77). A critical red flag is the 600% dividend payout ratio, which is mathematically unsustainable, coupled with a severe 65.6% YoY revenue decline. The bearish technical trend (10/100) and consistent earnings misses further reinforce a negative outlook.